Natasha Emmanuel1, Kristopher A Lofgren2, Esther A Peterson1, David R Meier2, Eric H Jung1, Paraic A Kenny3,4. 1. Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, U.S.A. 2. Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A. 3. Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A. pakenny@gundersenhealth.org. 4. Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, U.S.A.
Abstract
BACKGROUND/AIM: GATA3, a transcription factor expressed in luminal breast epithelial cells, is required for mammary gland development. Heterozygous GATA3 mutations occur in up to 15% of estrogen receptor (ER)-positive breast tumors and have been proposed to be null alleles resulting in haploinsufficiency; however, the mutation spectrum of GATA3 in breast cancer is in sharp contrast to that found in HDR syndrome, a true GATA3 haploinsufficiency disease. MATERIALS AND METHODS: Transgenic mice, 3D cultures and xenografts were used to examine the effect of mutant GATA3 expression on mammary cell proliferation. RESULTS: Mutant GATA3 accelerated tumor growth of ZR751 cell xenografts and promoted precocious lobuloalveolar development in transgenic mouse mammary glands. CONCLUSION: GATA3 mutations, recently observed in breast cancer, encode active transcription factors, which elicit proliferative phenotypes in normal mammary epithelium and promote the growth of ER-positive breast cancer cell lines. Copyright
BACKGROUND/AIM: GATA3, a transcription factor expressed in luminal breast epithelial cells, is required for mammary gland development. Heterozygous GATA3 mutations occur in up to 15% of estrogen receptor (ER)-positive breast tumors and have been proposed to be null alleles resulting in haploinsufficiency; however, the mutation spectrum of GATA3 in breast cancer is in sharp contrast to that found in HDR syndrome, a true GATA3haploinsufficiency disease. MATERIALS AND METHODS:Transgenic mice, 3D cultures and xenografts were used to examine the effect of mutant GATA3 expression on mammary cell proliferation. RESULTS: Mutant GATA3 accelerated tumor growth of ZR751 cell xenografts and promoted precocious lobuloalveolar development in transgenicmouse mammary glands. CONCLUSION:GATA3 mutations, recently observed in breast cancer, encode active transcription factors, which elicit proliferative phenotypes in normal mammary epithelium and promote the growth of ER-positive breast cancer cell lines. Copyright
Authors: H Van Esch; P Groenen; M A Nesbit; S Schuffenhauer; P Lichtner; G Vanderlinden; B Harding; R Beetz; R W Bilous; I Holdaway; N J Shaw; J P Fryns; W Van de Ven; R V Thakker; K Devriendt Journal: Nature Date: 2000-07-27 Impact factor: 49.962
Authors: S Gruvberger; M Ringnér; Y Chen; S Panavally; L H Saal; M Fernö; C Peterson; P S Meltzer Journal: Cancer Res Date: 2001-08-15 Impact factor: 12.701
Authors: Katherine U Gaynor; Irina V Grigorieva; Michael D Allen; Christopher T Esapa; Rosemary A Head; Preethi Gopinath; Paul T Christie; M Andrew Nesbit; J Louise Jones; Rajesh V Thakker Journal: Horm Cancer Date: 2013-02-22 Impact factor: 3.869
Authors: Jérôme Eeckhoute; Erika Krasnickas Keeton; Mathieu Lupien; Susan A Krum; Jason S Carroll; Myles Brown Journal: Cancer Res Date: 2007-07-01 Impact factor: 12.701
Authors: Jerry Usary; Victor Llaca; Gamze Karaca; Shafaq Presswala; Mehmet Karaca; Xiaping He; Anita Langerød; Rolf Kåresen; Daniel S Oh; Lynn G Dressler; Per E Lønning; Robert L Strausberg; Stephen Chanock; Anne-Lise Børresen-Dale; Charles M Perou Journal: Oncogene Date: 2004-10-07 Impact factor: 9.867
Authors: Matthew J Ellis; Li Ding; Dong Shen; Jingqin Luo; Vera J Suman; John W Wallis; Brian A Van Tine; Jeremy Hoog; Reece J Goiffon; Theodore C Goldstein; Sam Ng; Li Lin; Robert Crowder; Jacqueline Snider; Karla Ballman; Jason Weber; Ken Chen; Daniel C Koboldt; Cyriac Kandoth; William S Schierding; Joshua F McMichael; Christopher A Miller; Charles Lu; Christopher C Harris; Michael D McLellan; Michael C Wendl; Katherine DeSchryver; D Craig Allred; Laura Esserman; Gary Unzeitig; Julie Margenthaler; G V Babiera; P Kelly Marcom; J M Guenther; Marilyn Leitch; Kelly Hunt; John Olson; Yu Tao; Christopher A Maher; Lucinda L Fulton; Robert S Fulton; Michelle Harrison; Ben Oberkfell; Feiyu Du; Ryan Demeter; Tammi L Vickery; Adnan Elhammali; Helen Piwnica-Worms; Sandra McDonald; Mark Watson; David J Dooling; David Ota; Li-Wei Chang; Ron Bose; Timothy J Ley; David Piwnica-Worms; Joshua M Stuart; Richard K Wilson; Elaine R Mardis Journal: Nature Date: 2012-06-10 Impact factor: 49.962
Authors: Daniela Nachmanson; Adam Officer; Hidetoshi Mori; Jonathan Gordon; Mark F Evans; Joseph Steward; Huazhen Yao; Thomas O'Keefe; Farnaz Hasteh; Gary S Stein; Kristen Jepsen; Donald L Weaver; Gillian L Hirst; Brian L Sprague; Laura J Esserman; Alexander D Borowsky; Janet L Stein; Olivier Harismendy Journal: NPJ Breast Cancer Date: 2022-01-13